Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 6, Pages e2876
Publisher
Springer Nature
Online
2017-06-15
DOI
10.1038/cddis.2017.265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
- (2017) Wen Wen Xu et al. Nature Communications
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA
- (2016) L-Z Xu et al. ONCOGENE
- Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma
- (2015) Mingxin Zhang et al. BMC CANCER
- Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance
- (2015) B. Li et al. CLINICAL CANCER RESEARCH
- p62 links autophagy and Nrf2 signaling
- (2015) Tao Jiang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Finding Missing Proteins from the Epigenetically Manipulated Human Cell with Stringent Quality Criteria
- (2015) Lijuan Yang et al. JOURNAL OF PROTEOME RESEARCH
- Functional Role of NRF2 in Cervical Carcinogenesis
- (2015) Jun-Qi Ma et al. PLoS One
- Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan
- (2014) Te-Hsin Chao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
- (2014) Hong-Min Ni et al. JOURNAL OF HEPATOLOGY
- HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
- (2014) Banzhou Pan et al. Molecular Cancer
- Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death
- (2014) X Zou et al. Cell Death & Disease
- Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
- (2013) Ansgar Bruning Anti-Cancer Agents in Medicinal Chemistry
- Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
- (2013) Hui Sun et al. Anti-Cancer Agents in Medicinal Chemistry
- Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific
- (2013) Tong Wang et al. NUCLEIC ACIDS RESEARCH
- Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma
- (2013) Guang-Rong Yan et al. PROTEOMICS
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
- (2013) X Sui et al. Cell Death & Disease
- Sesquiterpene Lactones Isolated fromElephantopus scaberL. Inhibits Human Lymphocyte Proliferation and the Growth of Tumour Cell Lines and Induces ApoptosisIn Vitro
- (2012) B. S. Geetha et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2-M Cell-Cycle Progression
- (2012) S. Kastner et al. MOLECULAR CANCER RESEARCH
- Liver-Specific Loss of Atg5 Causes Persistent Activation of Nrf2 and Protects Against Acetaminophen-Induced Liver Injury
- (2012) Hong-Min Ni et al. TOXICOLOGICAL SCIENCES
- Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells
- (2011) Miaoxian Su et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
- (2011) Keiko Taguchi et al. GENES TO CELLS
- Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
- (2011) Yoshihiro Inami et al. JOURNAL OF CELL BIOLOGY
- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
- (2011) Adam Lister et al. Molecular Cancer
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice
- (2010) Chi-Chang Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Methods in Mammalian Autophagy Research
- (2010) Noboru Mizushima et al. CELL
- p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
- (2010) Ashish Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer
- (2010) Li-Ping Li et al. PROTEOMICS
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Pathogenesis of lung cancer signalling pathways: roadmap for therapies
- (2009) E. Brambilla et al. EUROPEAN RESPIRATORY JOURNAL
- Combination of FASP and StageTip-Based Fractionation Allows In-Depth Analysis of the Hippocampal Membrane Proteome
- (2009) Jacek R. Wiśniewski et al. JOURNAL OF PROTEOME RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Plant-derived compounds in clinical trials
- (2007) A SAKLANI et al. DRUG DISCOVERY TODAY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started